Innovative Handheld Biosensor Screening System

Innovative Handheld Biosensor Screening System

Several graduated cylinders of various thickness and heights with white side markings in front of a large beaker. They are all filled about halfway with red or blue chemical compounds. The blue ink is showing signs of Brownian motion when dissolving into water.

This post is also available in: heעברית (Hebrew)

Biosensors can be useful for businesses as well as for security and defense organizations. BioMensio from Finland is developing a smart handheld bio-screening sensor and associated cloud services to determine the presence of specific biomolecules.

Rapid and accurate on-site testing enables fast and targeted action in the presence of multiple unwanted substances from a biological liquid based sample.

The BioMensio biosensors allow cost efficient application development for businesses and governmental organizations in food and beverage, healthcare, security and defense segments as well as environmental monitoring area”, comments Ilari Antila, the company’s CEO, according to prweb.com.

According to the company’s website, the micro-array platform facilitates rapid development of new bioscreening applications for on-site testing. Initial applications include detection of multiple biological targets in saliva, food and milk safety applications, as well as point-of-care and bio-security applications.

Multiple MSMA pixels functionalized with a biologically active layer, like antibodies or DNA, enable unique capability to screen for multiple biological targets from the same liquid sample in one step.

BioMensio sensing technology is scalable and robust – neither optics nor moving parts are required. Detection mechanism is inherently suitable for any kind of analyte without costly labelling procedures.

BioMensio’s expertise is based on VTT Technical Research Centre of Finland with know-how of Siemens’ Research Labs.

Universality and simplicity are the main advantages of BioMensio label-free technologies. No labelling or analyte modifications are necessary unlike with traditional techniques. This makes the BioMensio sensor inherently universal and applicable to any analyte, or even DNA, on the lab-on-a-chip platform.

The company recently announced a €2.5 million funding round. It will also receive from  the investor consortium access to extensive knowledge and an industry network.